A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Kuemmel, S; Campone, M; Loirat, D; Lopez, RL; Beck, JT; De Laurentiis, M; Im, SA; Kim, SB; Kwong, A; Steger, GG; Adelantado, EZ; Duhoux, FP; Greil, R; Kuter, I; Lu, YS; Tibau, A; Özgüroğlu, M; Scholz, CW; Singer, CF; Vega, E; Wimberger, P; Zamagni, C; Couillebault, XM; Fan, L; Guerreiro, N; Mataraza, J; Sand-Dejmek, J; Chan, A. Clin Cancer Res. 2022 Jan 1;28(1):106-115. doi: 10.1158/1078-0432.CCR-20-3955. Epub 2021 Oct 6.

Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.

Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L. BMC Cancer. 2022 Jan 10;22(1):51. doi: 10.1186/s12885-021-09115-6.

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.

Bartsch, R; Gampenrieder, SP; Rinnerthaler, G; Petru, E; Egle, D; Petzer, A; Balic, M; Pluschnig, U; Sliwa, T; Singer, C. Wien Klin Wochenschr. 2022 Jan;134(1-2):63-72. doi: 10.1007/s00508-021-01987-9. Epub 2022 Jan 28.

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).

Gnant, M; Dueck, AC; Frantal, S; Martin, M; Burstein, HJ; Greil, R; Fox, P; Wolff, AC; Chan, A; Winer, EP; Pfeiler, G; Miller, KD; Colleoni, M; Suga, JM; Rubovsky, G; Bliss, JM; Mayer, IA; Singer, CF; Nowecki, Z; Hahn, O; Thom-son, J; Wolmark, N; Amillano, K; Rugo, HS; Steger, GG; Hernando Fernández de Aránguiz, B; Haddad, TC; Perelló, A; Bellet, M; Fohler, H; Metzger Filho, O; Jallitsch-Halper, A; Solomon, K; Schurmans, C; Theall, KP; Lu, DR; Tenner, K; Fesl, C; DeMichele, A; Mayer, EL. J Clin Oncol. 2022 Jan 20;40(3):282-293. doi: 10.1200/JCO.21.02554. Epub 2021 Dec 7.

Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation.

Härzschel A, Li L, Krenn PW, Szenes-Nagy E, Andrieux G, Bayer E, Pfei-fer D, Polcik L, Denk U, Höpner JP, Karabatak E, Danner DJ, Tangermann S, Kenner L, Jumaa H, Greil R, Börries M, Ruppert R, Maity PC, Hartmann TN. J Leukoc Biol. 2021 Dec 10. doi: 10.1002/JLB.1HI0621-313R. Online ahead of print. PMID: 34888947

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.

Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R. Breast Cancer Res. 2021 Dec 14;23(1):112. doi: 10.1186/s13058-021-01492-x.

Persistence of ctDNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumour response.

Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E. Clin Cancer Res. 2021 Dec 3. doi: 10.1158/1078-0432.CCR-21-3231. On-line ahead of print.

Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer.

Balic, M; Rinnerthaler, G; Bartsch, R. Breast Care (Basel). 2021 Dec;16(6):664-676. doi: 10.1159/000518696. Epub 2021 Oct 29.

Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition.

Peer, E; Aichberger, SK; Vilotic, F; Gruber, W; Parigger, T; Grund-Groschke, S; Elmer, DP; Rathje, F; Ramspacher, A; Zaja, M; Michel, S; Hamm, S; Aberger, F. Cancers (Basel). 2021 Aug 23;13(16):4227. doi: 10.3390/cancers13164227.

Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.

Binder, HM; Maeding, N; Wolf, M; Cronemberger Andrade, A; Vari, B; Krisch, L; Gomes, FG; Blöchl, C; Muigg, K; Poupardin, R; Raninger, AM; Heuser, T; Obermayer, A; Ebner-Peking, P; Pleyer, L; Greil, R; Huber, CG; Schallmoser, K; Strunk, D. Cells. 2021 Nov 26;10(12):3321. doi: 10.3390/cells10123321.